Tyra Biosciences (TYRA) Total Non-Current Liabilities (2020 - 2025)

Tyra Biosciences (TYRA) has 6 years of Total Non-Current Liabilities data on file, last reported at $23.4 million in Q4 2025.

• Quarterly Total Non-Current Liabilities rose 14.84% year-over-year to $23.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.4 million (up 14.84% YoY) and the FY2025 annual result came in at $23.4 million, up 14.84% from the prior year.
• Total Non-Current Liabilities advanced to $23.4 million in Q4 2025, from $21.3 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $23.4 million in Q4 2025 to a low of $4.6 million in Q4 2021.
• A 5-year average of $14.0 million and a median of $15.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 163.34% in 2023, down 18.15% in 2023.
• Tracing TYRA's Total Non-Current Liabilities over 5 years: stood at $4.6 million in 2021, then surged by 78.01% to $8.2 million in 2022, then surged by 163.34% to $21.5 million in 2023, then retreated by 5.31% to $20.4 million in 2024, then rose by 14.84% to $23.4 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $23.4 million (Q4 2025), $21.3 million (Q3 2025), and $19.4 million (Q2 2025), per Business Quant data.